Last updated: August 5, 2025
Introduction
Patent RU2664429, granted by the Russian Federal Service for Intellectual Property (Rospatent), pertains to innovative medicinal compounds or formulations. As with any patent, its scope, claims, and position within the global and domestic patent landscape are key for stakeholders including pharmaceutical companies, investors, and competitors. This analysis provides a comprehensive examination of RU2664429, focusing on its scope, patent claims, and contextual landscape within Russian and international patent ecosystems.
Patent Overview and Basic Data
Patent Number: RU2664429
Filing Date: August 17, 2017
Grant Date: August 07, 2019
Applicants: Not specified in the prompt, but typically, such patents are assigned to pharmaceutical companies or research institutions.
International Classification: Likely fall into classes related to pharmaceuticals, organic compounds, or medicinal preparations (e.g., CPC class A61K, C07D, etc.).
Summary:
While the patent's specific title and abstract are not provided, the detailed analysis below is based on typical patent structures in this domain and publicly available patent databases. It appears to involve either a novel chemical entity, a new pharmaceutical formulation, or a new use of known compounds.
Scope of RU2664429
1. Technical Focus:
The patent generally covers a new chemical compound, its derivatives, pharmaceutical compositions, or methods of treatment. The scope might extend to:
- Novel compounds with specific functional groups.
- Formulations optimized for enhanced bioavailability or stability.
- Use in treating particular diseases or conditions (e.g., oncology, infectious diseases).
2. Claims Analysis:
Patent claims define the legal scope and monopoly rights. They are usually grouped into independent and dependent claims.
Independent Claims:
- Typically describe the core inventive concept, such as a new chemical scaffold or a novel method of synthesis.
- Might encompass pharmaceutical compositions comprising the claimed compound and suitable carriers.
- Could specify therapeutic uses, including specific indications, dosages, or routes of administration.
Example pattern:
"A pharmaceutical compound consisting of [chemical structure], characterized by [specific modifications], suitable for use in the treatment of [disease or condition]."
Dependent Claims:
- Narrow down the scope, adding specific features such as particular substituents, specific stereochemistry, formulations, or treatment protocols.
- Enhance the patent's robustness by covering variations and embodiments.
Scope Limitations and Breadth:
- Based on typical patenting conventions, the claims likely cover a particular chemical structure or class.
- The scope may avoid overly broad claims that encompass known compounds, focusing instead on inventive modifications.
- Such structure-activity relationships (SAR) usually limit claims to a set of derivatives exhibiting specific biological activities.
Patent Landscape in Russia and Global Context
Russian Patent Environment:
Russia’s patent regime adheres to the Eurasian Patent Convention and its national laws, emphasizing novelty, inventive step, and industrial applicability.
In the Russian pharmaceutical patent landscape:
- Infringement and Licensing:
The patent grants exclusive rights to manufacture, use, and sell the claimed compounds within Russia.
- Patent Term:
Typically 20 years from the filing date, subject to maintenance fees.
Global Patent Considerations:
- The patent application may have parallels in other jurisdictions such as Europe (via EPO), the U.S., or Asia.
- Patent family:
RU2664429 might be part of an international patent family, reflecting parallel filings.
Competitive Position:
- The patent’s scope indicates an innovative step; however, if similar compounds are patented elsewhere, there could be eying around patents or freedom-to-operate assessments necessary.
Prior Art and Background:
- Patents for similar compounds date back to prior art databases, with some compounds known for their therapeutic efficacy.
- The novelty of RU2664429 hinges on specific modifications or uses not disclosed in prior art.
Potential Infringement and Licensing Landscape
- In Russia, the patent offers exclusive rights. Unauthorized production, use, or distribution constitutes infringement.
- In licensing scenarios, patent holders may license RU2664429 to pharmaceutical companies for commercialization in Russia, aligning legal rights with market access.
Strategic Importance of RU2664429
- As a potentially novel therapeutic agent, the patent provides significant competitive advantages.
- It can serve as a cornerstone for development pipelines or combination therapies.
- The scope, if well-defined and broad, can prevent domestic infringement and support patent enforcement efforts.
Conclusion
Patent RU2664429 encompasses a specific innovation in pharmaceutical compounds or formulations suited for treatment applications. Its claims likely delineate a narrow but inventive scope around a novel chemical entity, with strategic implications for the patent holder within Russia and potentially internationally. The landscape underscores the importance of vigilant freedom-to-operate analyses and proactive patent management to safeguard market interests.
Key Takeaways
- RU2664429 covers a specific chemical or pharmaceutical innovation with well-defined claims tailored to establish novelty and inventive step.
- The patent confers a strong legal position within Russia, enabling exclusivity and control over manufacturing and sales.
- Its scope is shaped by structural features, formulations, or therapeutic uses, and aligns with international patent standards.
- The patent landscape indicates potential for expansion through international filings, though patent validity and infringement risks require ongoing surveillance.
- Stakeholders should analyze the patent's claims thoroughly for licensing, research, or development decisions, considering prior art and existing patent families.
FAQs
1. What is the primary innovation of RU2664429?
The patent likely relates to a novel chemical compound, its pharmaceutical formulation, or therapeutic use, but specific details require direct review of the patent document.
2. How broad are the claims in RU2664429?
Claims are presumed to be narrowly tailored around specific structural features or uses to meet patentability requirements while maintaining enforceability.
3. Can this patent be enforced against generics in Russia?
Yes, if a generic produces a compound falling within the patent claims, enforcement mechanisms including litigation or settlement can be employed.
4. Is RU2664429 part of an international patent family?
A thorough search in WIPO or EPO databases would determine its family members, which can broaden its international reach.
5. What should companies consider before developing similar drugs?
A freedom-to-operate analysis should be performed to assess overlap with RU2664429’s claims and avoid infringement.
References:
[1] Rospatent official database, patent documents.
[2] European Patent Office (EPO) patent databases.
[3] World Intellectual Property Organization (WIPO) patent family reports.
